Welcome to LookChem.com Sign In|Join Free
  • or
1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is a chemical compound with the molecular formula C8H10N6. It is a derivative of pyrazolo[3,4-d]pyrimidine and contains an amine group. 1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine has potential biological and pharmacological properties, including antiviral and antitumor activities. It may be used in medicinal chemistry research for the development of new drugs and pharmaceuticals. The specific properties and uses of 1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine may vary depending on its application and research context.

5346-58-7

Post Buying Request

5346-58-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5346-58-7 Usage

Uses

Used in Pharmaceutical Industry:
1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is used as a pharmaceutical candidate for its potential antiviral and antitumor activities. It is being researched for its potential use in the development of new drugs and pharmaceuticals to treat various diseases and conditions.
Used in Medicinal Chemistry Research:
1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is used as a research compound in medicinal chemistry to explore its biological and pharmacological properties. Its unique structure and potential activities make it a valuable tool for understanding the mechanisms of action and developing new therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 5346-58-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,4 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5346-58:
(6*5)+(5*3)+(4*4)+(3*6)+(2*5)+(1*8)=97
97 % 10 = 7
So 5346-58-7 is a valid CAS Registry Number.

5346-58-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3-dimethylpyrazolo[3,4-d]pyrimidin-4-amine

1.2 Other means of identification

Product number -
Other names 1,3-dimethyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5346-58-7 SDS

5346-58-7Relevant academic research and scientific papers

1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D

Kulkarni, Aditya,Quang, Phong,Curry, Victoriana,Keyes, Renee,Zhou, Weihong,Cho, Hyejin,Baffoe, Jonathan,T?r?k, Béla,Stieglitz, Kimberly

, p. 270 - 281 (2014/10/15)

Phospholipase D enzymes cleave lipid substrates to produce phosphatidic acid, an important precursor for many essential cellular molecules. Phospholipase D is a target to modulate cancer-cell invasiveness. This study reports synthesis of a new class of phospholipase D inhibitors based on 1,3-disubstituted-4-amino-pyrazolopyrimidine core structure. These molecules were synthesized and used to perform initial screening for the inhibition of purified bacterial phospholipase D, which is highly homologous to the human PLD1. Initially tested with the bacterial phospholipase D enzyme, then confirmed with the recombinant human PLD1 and PLD2 enzymes, the molecules presented here exhibited inhibition of phospholipase D activity (IC50) in the low-nanomolar to low-micromolar range with both monomeric substrate diC4PC and phospholipid vesicles and micelles. The data strongly indicate that these inhibitory molecules directly block enzyme/vesicle substrate binding. Preliminary activity studies using recombinant human phospholipase Ds in in vivo cell assays measuring both transphosphatidylation and head-group cleavage indicate inhibition in the mid- to low-nanomolar range for these potent inhibitory novel molecules in a physiological environment. This study reports synthesis of a new class of PLD inhibitors based on 1,3-disubstituted-4-amino-pyrazolopyrimidine core structure. These molecules exhibited inhibition of human recombinant PLD activity (IC 50) in the low-nanomolar to low-micromolar range with monomeric substrate diC4PC and phospholipid vesicles and micelles. Preliminary activity studies using recombinant human PLDs in in vivo cell assays measuring both transphosphatidylation and head-group cleavage indicates inhibition in the mid- to low-nanomolar range for these potent inhibitory novel molecules in a physiological environment.

Synthesis and characterization of two novel organic-inorganic compounds based on tetrahexyl and Tetraheptyl ammonium ions and the preyssler anion and their catalytic activities in the synthesis of 4-aminopyrazolo[3,4-d]- pyrimidines

Bamoharram, Fatemeh Farrash

experimental part, p. 2509 - 2519 (2010/07/15)

Two novel organic-inorganic compounds based on tetrahexylammonium (THA) and tetraheptylammonium (THPA) ions and the Preyssler anion, [NaP5W30O110]14-, were synthesized and formulated as (THA)7.7H6.3 [NaP5W30O110] (A) and (THPA)7.5 H6.5[N aP5W30O110] (B).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5346-58-7